NRX Pharmaceuticals, Inc. (NRXP)
2.075
-0.12
(-5.68%)
USD |
NASDAQ |
Dec 12, 16:00
2.05
-0.02
(-1.20%)
After-Hours: 20:00
NRX Pharmaceuticals Research and Development Expense (Annual): 6.199M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Synergy CHC Corp. | -- |
| Acurx Pharmaceuticals, Inc. | 5.404M |
| IGC Pharma, Inc. | 3.655M |
| CEL-SCI Corp. | 18.16M |
| AIM ImmunoTech, Inc. | 6.149M |